cloudfront

Report Detail

Pharma & Healthcare Global Pemetrexed Market Insights, Forecast to 2025

  • RnM3144820
  • |
  • 17 April, 2019
  • |
  • Global
  • |
  • 110 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Pemetrexed Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Pemetrexed Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Pemetrexed Market Size Growth Rate by Product
      • 1.4.2 100mg
      • 1.4.3 500mg
    • 1.5 Market by End User
      • 1.5.1 Global Pemetrexed Market Size Growth Rate by End User
      • 1.5.2 Pleural Mesothelioma
      • 1.5.3 Non-small Cell Lung Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Pemetrexed Market Size
      • 2.1.1 Global Pemetrexed Revenue 2014-2025
      • 2.1.2 Global Pemetrexed Sales 2014-2025
    • 2.2 Pemetrexed Growth Rate by Regions
      • 2.2.1 Global Pemetrexed Sales by Regions
      • 2.2.2 Global Pemetrexed Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Pemetrexed Sales by Manufacturers
      • 3.1.1 Pemetrexed Sales by Manufacturers
      • 3.1.2 Pemetrexed Sales Market Share by Manufacturers
      • 3.1.3 Global Pemetrexed Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pemetrexed Revenue by Manufacturers
      • 3.2.1 Pemetrexed Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pemetrexed Revenue Share by Manufacturers (2014-2019)
    • 3.3 Pemetrexed Price by Manufacturers
    • 3.4 Pemetrexed Manufacturing Base Distribution, Product Types
      • 3.4.1 Pemetrexed Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Pemetrexed Product Type
      • 3.4.3 Date of International Manufacturers Enter into Pemetrexed Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Pemetrexed Sales by Product
    • 4.2 Global Pemetrexed Revenue by Product
    • 4.3 Pemetrexed Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Pemetrexed Breakdown Data by End User

    6 North America

    • 6.1 North America Pemetrexed by Countries
      • 6.1.1 North America Pemetrexed Sales by Countries
      • 6.1.2 North America Pemetrexed Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Pemetrexed by Product
    • 6.3 North America Pemetrexed by End User

    7 Europe

    • 7.1 Europe Pemetrexed by Countries
      • 7.1.1 Europe Pemetrexed Sales by Countries
      • 7.1.2 Europe Pemetrexed Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Pemetrexed by Product
    • 7.3 Europe Pemetrexed by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Pemetrexed by Countries
      • 8.1.1 Asia Pacific Pemetrexed Sales by Countries
      • 8.1.2 Asia Pacific Pemetrexed Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Pemetrexed by Product
    • 8.3 Asia Pacific Pemetrexed by End User

    9 Central & South America

    • 9.1 Central & South America Pemetrexed by Countries
      • 9.1.1 Central & South America Pemetrexed Sales by Countries
      • 9.1.2 Central & South America Pemetrexed Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Pemetrexed by Product
    • 9.3 Central & South America Pemetrexed by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Pemetrexed by Countries
      • 10.1.1 Middle East and Africa Pemetrexed Sales by Countries
      • 10.1.2 Middle East and Africa Pemetrexed Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Pemetrexed by Product
    • 10.3 Middle East and Africa Pemetrexed by End User

    11 Company Profiles

    • 11.1 Eli Lilly
      • 11.1.1 Eli Lilly Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Eli Lilly Pemetrexed Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Eli Lilly Pemetrexed Products Offered
      • 11.1.5 Eli Lilly Recent Development
    • 11.2 Abbott Healthcare
      • 11.2.1 Abbott Healthcare Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott Healthcare Pemetrexed Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott Healthcare Pemetrexed Products Offered
      • 11.2.5 Abbott Healthcare Recent Development
    • 11.3 Cadila Healthcare
      • 11.3.1 Cadila Healthcare Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cadila Healthcare Pemetrexed Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cadila Healthcare Pemetrexed Products Offered
      • 11.3.5 Cadila Healthcare Recent Development

    12 Future Forecast

    • 12.1 Pemetrexed Market Forecast by Regions
      • 12.1.1 Global Pemetrexed Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Pemetrexed Revenue Forecast by Regions 2019-2025
    • 12.2 Pemetrexed Market Forecast by Product
      • 12.2.1 Global Pemetrexed Sales Forecast by Product 2019-2025
      • 12.2.2 Global Pemetrexed Revenue Forecast by Product 2019-2025
    • 12.3 Pemetrexed Market Forecast by End User
    • 12.4 North America Pemetrexed Forecast
    • 12.5 Europe Pemetrexed Forecast
    • 12.6 Asia Pacific Pemetrexed Forecast
    • 12.7 Central & South America Pemetrexed Forecast
    • 12.8 Middle East and Africa Pemetrexed Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Pemetrexed Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Pemetrexed market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pemetrexed market based on company, product type, end user and key regions.

      This report studies the global market size of Pemetrexed in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pemetrexed in these regions.
      This research report categorizes the global Pemetrexed market by top players/brands, region, type and end user. This report also studies the global Pemetrexed market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Eli Lilly
      Abbott Healthcare
      Cadila Healthcare

      Market size by Product
      100mg
      500mg
      Market size by End User
      Pleural Mesothelioma
      Non-small Cell Lung Cancer

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Pemetrexed market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Pemetrexed market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Pemetrexed companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Pemetrexed submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Pemetrexed are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pemetrexed market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Pemetrexed . Industry analysis & Market Report on Pemetrexed is a syndicated market report, published as Global Pemetrexed Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pemetrexed market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,618.85
      3,928.28
      5,237.70
      3,588.78
      5,383.17
      7,177.56
      472,446.00
      708,669.00
      944,892.00
      258,622.26
      387,933.39
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report